Screening Strategy for Asymptomatic Sexually Transmitted Infections (STI) in a Cohort of HIV Outpatients Men Who Have Sex With Men (DRIVER)

NCT02413632 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 495

Last updated 2018-07-16

No results posted yet for this study

Summary

Comparison of two screening strategies of asymptomatic sexually transmitted infections : routine screening versus screening as reported by the risks taken by the patient, in a cohort of HIV outpatients men who have sex with men. The aim of this study will be create and validate a simple tool for clinicians. A digital tool will be developed will allowed empowerment of HIV-positive men who have sex with men.

Conditions

Interventions

OTHER

creation of a STIs score risk

4 questionnaires 3 screening test ( syphilis, chlamydia, gonorrhea)

OTHER

validation of a STIs score risk

DRIVER questionnaire (DRIVER STI score risk) 3 screening test ( syphilis, chlamydia, gonorrhea)

Sponsors & Collaborators

  • Saint-Louis Hospital, Paris, France

    collaborator OTHER
  • Bicetre Hospital

    collaborator OTHER
  • Hotel Dieu Hospital

    collaborator OTHER
  • European Georges Pompidou Hospital

    collaborator OTHER
  • Hôpital Necker-Enfants Malades

    collaborator OTHER
  • Hôpital Franco-Britannique

    collaborator UNKNOWN
  • Institut Mutualiste Montsouris

    collaborator OTHER
  • Hôpital Lagny Marne la Vallée

    collaborator UNKNOWN
  • Hôpital Raymond Poincaré

    collaborator OTHER
  • Centre Hospitalier Argenteuil

    collaborator OTHER
  • Hôpital Louis Mourier

    collaborator OTHER
  • Hospital Ambroise Paré Paris

    collaborator OTHER
  • Hopital Foch

    lead OTHER

Principal Investigators

  • David ZUCMAN, MD · Hôpital Foch

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2017-04-14
Completion
2017-04-14

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02413632 on ClinicalTrials.gov